Rachael Easton
Director of Finance/CFO at GLADSTONE INVESTMENT CORPORATION
Profile
Rachael Easton is currently the Chief Financial Officer & Treasurer at Gladstone Investment Corp.
and the Vice President & Head-Clinical Development at Cogent Biosciences, Inc. She previously worked as the Sr. Medical Director-Oncology Clinical Development at GSK Plc.
Easton received her undergraduate degree from Washington & Lee University and her doctorate from Washington University School of Medicine.
Rachael Easton active positions
| Companies | Position | Start |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-11-27 |
| GLADSTONE INVESTMENT CORPORATION | Director of Finance/CFO | 2021-11-30 |
Former positions of Rachael Easton
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Training of Rachael Easton
| Washington & Lee University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| GSK PLC | Health Technology |
| Private companies | 1 |
|---|---|
Gladstone Investment Corp.
 Gladstone Investment Corp. Investment ManagersFinance Gladstone Investment Corp., a traded business development company invests in lower middle market companies located in the United States. The fund focuses on companies with an EBITDA of $3 to $20 million. It targets companies operating in the fields of manufacturing, consumer products and business and consumer services. It provides financing for debt, buyout and growth stage capital requirements with an investment size up to $75 million.. | Finance |
- Stock Market
- Insiders
- Rachael Easton